Junko Yamauchi

A pilot study suggests that the G/G genotype of resistin single nucleotide polymorphism at -420 may be an independent predictor of a reduction in fasting plasma glucose and insulin resistance by pioglitazone in type 2 diabetes.

Y. Tabara, H. Onuma, H. Makino, 2009, Endocrine journal.

Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.

Y. Tabara, T. Miki, Kazuya Yamada, 2005, Biochemical and biophysical research communications.

Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes

Y. Tabara, T. Miki, H. Onuma, 2008, Clinical endocrinology.

Hyperresistinemia Is Associated With Coexistence of Hypertension and Type 2 Diabetes

J. Higaki, T. Okura, H. Makino, 2008, Hypertension.

Serum resistin is associated with the severity of microangiopathies in type 2 diabetes.

H. Onuma, H. Makino, H. Osawa, 2007, Biochemical and biophysical research communications.

Serum resistin is reduced by glucose and meal loading in healthy human subjects.

Y. Tabara, T. Miki, H. Onuma, 2008, Metabolism: clinical and experimental.

Optimal placement of CVP catheter in paediatric cardiac patients

K. Maruyama, Y. Ohnishi, Y. Hayashi, 1995, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Reliability and Validity of the Index of Kyphosis on Sitting

S. Usuda, Junko Yamauchi, Kazufumi Araya, 2004 .